Constantijn G. Bauland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Constantijn G. Bauland has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Jeroen M. Smit
1 shared publication- Maurice Adrianus Monique van Steensel
Lee Kong Chian School of Medicine, Nanyang Technological University, Republic of Singapore
1 shared publication Paul H. M. Spauwen
1 shared publicationPaul H.M. Spauwen
1 shared publicationPaul N. M. A. Rieu
1 shared publicationPaul N.M.A. Rieu
1 shared publication
Latest Publications
- 1 January 2008
- Published by Taylor & Francis in Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery
- Vol. 42 (2) , 86-91
Management of haemangiomas of infancy: A retrospective analysis and a treatment protocol
Haemangiomas of infancy are common benign endothelial neoplasms that affect roughly 1:10 children. Treatment is indicated in complicated cases. We have evaluated treatment in a multidisciplinary setting. The charts of all affected patients between 1985 and 2000 were reviewed. The personal details, complications, indications for treatment, and outcome, were evaluated. Treatment was started in 77 of the 282 cases reviewed. Ulceration and bleeding were the most common complications and were successfully treated when indicated in 29/39 patients (74%) with wound dressings and antibiotics. Systemic steroids were given to 18 patients, usually for block of the visual fields and respiratory impairment. A good or moderate result was obtained in 16/18 patients. Twelve patients required operation. Based on our results and those of others, we propose a protocol for treatment.
- 1 January 2008
- Published by Taylor & Francis in Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery
- Vol. 42 (2) , 86-91
Management of haemangiomas of infancy: A retrospective analysis and a treatment protocol
Haemangiomas of infancy are common benign endothelial neoplasms that affect roughly 1:10 children. Treatment is indicated in complicated cases. We have evaluated treatment in a multidisciplinary setting. The charts of all affected patients between 1985 and 2000 were reviewed. The personal details, complications, indications for treatment, and outcome, were evaluated. Treatment was started in 77 of the 282 cases reviewed. Ulceration and bleeding were the most common complications and were successfully treated when indicated in 29/39 patients (74%) with wound dressings and antibiotics. Systemic steroids were given to 18 patients, usually for block of the visual fields and respiratory impairment. A good or moderate result was obtained in 16/18 patients. Twelve patients required operation. Based on our results and those of others, we propose a protocol for treatment.
- 1 February 2006
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 117 (2) , 29e-35e
The Pathogenesis of Hemangiomas: A Review
After reading this article, the participant should be able to: 1. Differentiate between hemangiomas and vascular malformations. 2. Describe arguments for the trophoblast origin of hemangiomas. 3. Give arguments for the angioblast theory for the origin of hemangiomas. 4. Identify key genes involved in the origin of hemangiomas. Hemangiomas of infancy are common endothelial tumors. They differ from vascular malformations in their tissue architecture and biological properties. To date, there is no universally accepted theory that explains the pathogenesis and pathophysiology of hemangiomas. Theories from the medical literature from 1981 to 2004 were gathered, categorized, and reviewed. Current research is mostly on the cellular and genetic levels. The most authoritative theories focus on angioblast origins, trophoblast origins, mutations in cytokine regulatory pathways, and field defects as the cause of the deranged angiogenesis of hemangiomas. To date, no single theory can easily explain all the characteristics of hemangiomas, such as predilection for the female sex, usual occurrence after birth, spontaneous involution, abnormal tissue architecture, and distribution within a developmental field. Hemangiomas are probably the final common expression of several pathophysiological mechanisms taking effect alone or in combination.
- 1 February 2006
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 117 (2) , 29e-35e
The Pathogenesis of Hemangiomas: A Review
After reading this article, the participant should be able to: 1. Differentiate between hemangiomas and vascular malformations. 2. Describe arguments for the trophoblast origin of hemangiomas. 3. Give arguments for the angioblast theory for the origin of hemangiomas. 4. Identify key genes involved in the origin of hemangiomas. Hemangiomas of infancy are common endothelial tumors. They differ from vascular malformations in their tissue architecture and biological properties. To date, there is no universally accepted theory that explains the pathogenesis and pathophysiology of hemangiomas. Theories from the medical literature from 1981 to 2004 were gathered, categorized, and reviewed. Current research is mostly on the cellular and genetic levels. The most authoritative theories focus on angioblast origins, trophoblast origins, mutations in cytokine regulatory pathways, and field defects as the cause of the deranged angiogenesis of hemangiomas. To date, no single theory can easily explain all the characteristics of hemangiomas, such as predilection for the female sex, usual occurrence after birth, spontaneous involution, abnormal tissue architecture, and distribution within a developmental field. Hemangiomas are probably the final common expression of several pathophysiological mechanisms taking effect alone or in combination.